What are the ASCO guidelines on long-term monitoring of men with breast cancer?

Updated: Feb 11, 2021
  • Author: Bagi RP Jana, MD, MBA, MHA, FACP; Chief Editor: John V Kiluk, MD, FACS  more...
  • Print


ASCO guidelines include the following recommendations regarding follow-up [12] :

  • Patients should be counseled about the symptoms of breast cancer recurrence, including new lumps, bone pain, chest pain, dyspnea, abdominal pain, or persistent headaches.

  • Continuity of care for patients with breast cancer is recommended and should be performed by a physician experienced in the surveillance of patients with cancer and in breast examination, including the examination of irradiated breasts.

  • Men with a history of breast cancer treated with lumpectomy should be offered ipsilateral annual mammography if technically feasible, regardless of genetic predisposition.

  • Men with a history of breast cancer and a genetic predisposing mutation may be offered contralateral annual mammography.

  • Breast magnetic resonance imaging is not routinely recommended in men with a history of breast cancer.

  • Male patients with breast cancer should be offered genetic counseling and genetic testing for germline mutations

In men with early-stage breast cancer who receive adjuvant GnRH analog therapy, NCCN guidelines recommend bone density assessment at baseline and every 2 years. Low bone density in those patients should be managed according to standard guidelines. [15]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!